Alkermes' Corporate Presentation to be Webcast at the Thomas Weisel Partners Annual Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 2, 2009--
Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live by Thomas Weisel Partners on
Wednesday, September 9, 2009, at 1:30 p.m. ET from the Four Seasons
Hotel in Boston. The presentation may be accessed under the investor
relations tab at www.alkermes.com.
The presentation will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to
developing innovative medicines to improve patients' lives. Alkermes
developed, manufactures and commercializes VIVITROL® for
alcohol dependence and manufactures RISPERDAL® CONSTA®
for schizophrenia and bipolar I disorder. Alkermes' robust pipeline
includes extended-release injectable, pulmonary and oral products for
the treatment of prevalent, chronic diseases, such as central nervous
system disorders, addiction and diabetes. Headquartered in Cambridge,
Massachusetts, Alkermes has research facilities in Massachusetts and a
commercial manufacturing facility in Ohio.
Source: Alkermes, Inc.
Eva Stroynowski, 617-583-6823